DVAX Competitors & Alternatives
Compare Dynavax Technologies Corporation with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
DVAX
Main Stock$15.50
Tradestie Score
48
Market Cap
$1.21B
Revenue Growth
0.2%
Analyst Upside
+41.9%
Top Competitors
44 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANIP
ANI Pharmaceuticals, Inc.
|
$72.61
|
$2.01B | 16.0 | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$42.65
|
$1.90B | 28.0 | 46 | Compare |
|
HROW
Harrow, Inc. Common Stock
|
$28.44
|
$1.79B | - | 60 | Compare |
|
PAHC
Phibro Animal Health Corporation Class A
|
$38.80
|
$1.65B | 16.2 | 51 | Compare |
|
BCRX
BioCryst Pharmaceuticals Inc
|
$7.65
|
$1.55B | - | 48 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$27.20
|
$1.49B | - | 54 | Compare |
|
AVDL
Avadel Pharmaceuticals plc Ordinary Share
|
$21.64
|
$1.46B | - | 48 | Compare |
|
EVO
Evotec SE American Depositary Shares
|
$1.50
|
$1.34B | - | 49 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$10.20
|
$1.29B | - | 44 | Compare |
|
AMPH
Amphastar Pharmaceuticals, Inc.
|
$25.14
|
$1.25B | 15.4 | 44 | Compare |
More DVAX Analysis
Data updated: Oct 23, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
44 stocks in this industry